4
Changes in Ownership
UNITED THERAPEUTICS Corp Filed Acc 0001106578-26-000104
Chairperson & CEO sold 9,500 shares at an average $530.57 ($5,040,380)
- Chairperson & CEO acquired 9,500 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
ROTHBLATT MARTINE A · Chairperson & CEO
Table I: Non-derivative
15 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2026-07-22 | Exercise or conversion : show line 1 in the form 10b5-1 | +9,500 | $135.42 | $1,286,490 | 333,943 | I |
| 2026-07-22 | Sale : show line 2 in the form 10b5-1 | −120 | $524.27 | $62,912 | 333,823 | I |
| 2026-07-22 | Sale : show line 3 in the form 10b5-1 | −485 | $526.04 | $255,131 | 333,338 | I |
| 2026-07-22 | Sale : show line 4 in the form 10b5-1 | −2,610 | $526.84 | $1,375,058 | 330,728 | I |
| 2026-07-22 | Sale : show line 5 in the form 10b5-1 | −1,211 | $527.82 | $639,189 | 329,517 | I |
| 2026-07-22 | Sale : show line 6 in the form 10b5-1 | −874 | $528.91 | $462,265 | 328,643 | I |
| 2026-07-22 | Sale : show line 7 in the form 10b5-1 | −760 | $529.80 | $402,645 | 327,883 | I |
| 2026-07-22 | Sale : show line 8 in the form 10b5-1 | −400 | $531.22 | $212,490 | 327,483 | I |
| Open-market sales · 9,500 sh · avg $530.57 · $5,040,380 | ||||||
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2026-07-22 | Exercise or conversion : show line 16 in the form 10b5-1 Stock Option | −9,500 | 293,910 | I |
Loading xslF345X06/primarydocument.xml…